| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9871982 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 6 Pages |
Abstract
Conclusion: With a median follow-up of 66 months, the long-term results after high-dose hypofractionation are excellent. Late toxicity, urinary and rectal, has been limited. High-dose hypofractionation is an alternative dose escalation method in the treatment of localized prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Patrick A. M.D., Vipul V. M.D., Deepak M.D., Chandana A. M.S., Eric A. M.D., Arul M.D.,